Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-06-10
1992-08-04
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544360, 544364, A61K 31495, C07D21374, C07D40104
Patent
active
051359316
ABSTRACT:
Disclosed are compounds displaying improved preferential serotonin-1A binding activity. The claimed compounds have the formula: ##STR1## wherein R.sub.1 is selected from the group consisting of hydroxy, halogen, lower alkyl, lower alkoxy, and hydrogen;
REFERENCES:
patent: 3488352 (1970-01-01), Schipper et al.
patent: 3574839 (1971-04-01), Schipper et al.
patent: 3705899 (1972-12-01), Regnier et al.
patent: 4510140 (1985-04-01), Nardi et al.
patent: 4882432 (1989-11-01), Abou-Gharbia et al.
patent: 4971969 (1990-11-01), Carlier et al.
patent: 4988814 (1991-01-01), Abou-Gharbia et al.
patent: 5010078 (1991-04-01), Abou-Gharbia et al.
patent: 5026853 (1991-06-01), Van Daele et al.
Catto et al, J. Med. Chem. 1987, 30, pp. 13-19.
March, Adv. Org. Chem. 3rd Edition, pp. 370-371.
Carlier Patrick
Monteil Andre
Poisson Claude
Akzo N.V.
Blackstone William M.
Bobrowicz Donna
Shen Cecilia
LandOfFree
Pyridinylpiperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinylpiperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinylpiperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778484